| [1] |
姜利宁，季德才，鄂文娜，等.完全不阻断肾动脉腹腔镜肾部分切除术治疗肾恶性肿瘤的效果[J].中国医药导报，2017，14（11）：79-82.
|
| [2] |
韩秀鑫，王国文，刘乐乐，等.肾细胞癌脊柱转移的治疗方法研究进展[J].山东医药，2018，58（15）：97-100.
|
| [3] |
Fairlamb DJ.Spontaneous regression of metastases of renal cancer：a report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature[J].Cancer，1981，47（8）：2102-2106.
|
| [4] |
Iannuccilli JD，Dupuy DE，Beland MD，et al.Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer：a 14-year single institution experience in 203 patients[J].Eur Radiol，2016，26（6）：1656-1664.
|
| [5] |
Le Q，Jin D，Cheng C，et al.Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA[J].Cancer Cell，2016，29（5）：653-668.
|
| [6] |
吴佳成，姜力.保留肾单位手术治疗偶发性肾癌11例临床分析[J].现代肿瘤医学，2018，26（11）：1744-1748
|
| [7] |
Haas NB，Manola J，Dutcher JP，et al.Adjuvant treatment for high-risk clear cell renal cancer：updated results of a highrisk subset of the ASSURE randomized trial[J].JAMA Oncol，2017，3（9）：1249-1252.
|
| [8] |
Wei R，Zhang C，Yang W.MiR-155 affects renal carcinoma cell proliferation，invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway[J].Eur Rev Med Pharmacol Sci，2017，21（22）：5034-5041.
|
| [9] |
Juan D，Alexe G，Antes T，et al.Identification of a microRNA panel for clear-cell kidney cancer[J].Urology，2010，75（4）：835-841.
|
| [10] |
Li M，Wang L.The associations of psychological stress with depressive and anxiety symptoms among Chinese bladder and renal cancer patients：the mediating role of resilience[J].PLoS One，2016，11（4）：e0154729.
|
| [11] |
Ji H，Tian D，Zhang B，et al.Overexpression of miR-155 in clear-cell renal cell carcinoma and its oncogenic effect through targeting FOXO3a[J].Exp Ther Medi，2017，13（5）：2286-2292.
|
| [12] |
Merhautová，J，Hézvá R，Poprach A，et al.miR-155 and miR-484 are associated with time to progression in metastatic renal cell carcinoma patients treated with sunitinib[J].Biomed Res Int，2015，2015：941 980.
|
| [14] |
竺王玉，张玉惠，张伟忠，等.hsa-microRNA-96-5p down慢病毒表达载体的构建与鉴定[J].医学研究杂志，2016，45（6）：108-111.
|
| [16] |
徐维田，郑国荣，熊毅敏，等.早期胃癌微小RNA表达谱的建立[J].华南国防医学杂志，2013，27（7）：464-467.
|
| [17] |
程文.微小RNA与肿瘤相关性研究[J].医学研究生学报，2011，24（2）：203-207.
|
| [13] |
Huang Y，Lee C，Lee J，et al.Epigenetic silencing of miR-137contributes to early colorectal carcinogenesis byimpaired Aurora-Ainhibition[J].Oncotarget，2016，7（47）：76852-76 866.
|
| [15] |
Ding WB，Wang YX，Dong CW.microRNA15b induced SMCC7721 apoptosis via down-regulation of XIAP[J].Eur Rev Med Pharmacol Sci，2017，21（3）：542-548.
|
| [18] |
Cao S，Wang Y，Li J，et al.Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function[J].Am J Cancer Res，2016，6（11）：2561-2574.
|
| [19] |
BacciM，GiannoniE，FearnsA，etal.miR-155drivesmetabolic reprogramming of ER+breast cancer cells following longterm estrogen deprivation and predicts clinical response to aromatase inhibitors[J].Cancer Res，2016，76（6）：1615-1626.
|
| [20] |
Gao Y，Ma X，Yao Y，et al.miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2[J].Oncotarget，2016，7（15）：20 324-20 337.
|
| [21] |
Ji H，Tian D，Zhang B，et al.Overexpression of miR-155 in clear-cell renal cell carcinoma and its oncogenic effect through targeting FOXO3a[J].Exp Ther Med，2017，13（5）：2286-2292.
|
